Alzheimer’s disease is the leading cause of dementia in the UK. It’s a complex, challenging, and devastating condition that causes a gradual decline in a person’s cognition, including memory and ...

New research is providing fresh support for the decades-old idea that viral infections can play a role in at least some ...

The initiative, called Holistic Optical Biomarkers to Transform Dementia Diagnosis (HOpE), is funded by UK Research and ...

POTOMAC, MD / ACCESSWIRE / October 17, 2024 / IGC Pharma, Inc (NYSE American:IGC) ("IGC" or the "Company"), today announced enrollment of patients at the Baycrest Academy for Research and Education in ...

On Thursday, Nexalin Technology, Inc (NASDAQ:NXL) (NASDAQ:NXLIW) announced results from a clinical trial of its Deep ...

Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar ...

Bipolar disorder has potential links to memory changes during and after depressive or manic episodes. Learn how states and ...

A new study across five European countries is the largest randomized controlled trial to date evaluating the efficacy of a ...

Medications and therapy are two of the most common treatments for anxiety, and they're highly effective. But there are also natural anxiety remedies like exercise, meditation and breathing ...

Africa has higher levels of genetic diversity than any other continent, providing great opportunity to investigate ...

They may complain of memory problems but perform well on cognitive tests. Treatment of dementia and pseudodementia may also vary. In depression-related pseudodementia, treating the underlying ...